Boston Scientific Acquires nVision Medical

Posted in Medical Device

April 16, 2018 • 3 min read

Boston Scientific announced the acquisition of nVision Medical, who developed the first and only device cleared by the U.S. Food and Drug Administration to collect cells from the fallopian tubes, offering a potential platform for earlier diagnosis of...

J&J Vision Announces Revolutionary Transitional Contact Lens

Posted in Medical Device

April 11, 2018 • 3 min read

Johnson & Johnson Vision just announced one of the more exciting new contact lens products to hit the market in years. They partnered with Transition Optical, the leading provider of photochromic (smart adaptive) lenses and came up with the ACUVUE OASYS...

Intersect ENT commercially launches SINUVA sinus implant

Posted in Medical Device

April 03, 2018 • 3 min read

Intersect ENT announced the commercial availability of their long-awaited SINUVA Sinus Implant yesterday. The SINUVA Sinus Implant provides a new approach to treating nasal polyp disease in adult patients who have had previous sinus surgery....

Abbott invests in diabetes startup Bigfoot Biomedical

Posted in Medical Device,

March 28, 2018 • 3 min read

One of the more ambitious and interesting early stage medtech companies, Bigfoot Biomedical, announced the final close of their Series B, bringing in $55 million, including an undisclosed investment from Abbott. The total funding to date is more than $90...

Boston Scientific Acquires NxThera for $406 Million

Posted in Medical Device

March 21, 2018 • 3 min read

The rumors have been discussed for two years that Boston Scientific would acquire NxThera, the developer of Rezum, a minimally invasive therapy that treats BPH (benign prostatic hyperplasia). Today Boston Scientific made it official, acquiring NxThera...

TransEnterix Earnings: What Did We Learn?

Posted in Medical Device,

March 08, 2018 • 3 min read

During their most recent earnings call, TransEnterix shared some notable highlights in regards to their cash position, expanded indications and the sale of two Senhance systems thus far in Q1 of 2018. ...